|
BUYINS.NET: ETH, NCC, ADEP, CBMX, CEGE, DRYS Have Been Added To Naked
Short List Today
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:01052008
BUYINS.NET, www.buyins.net, announced today that these select companies
have been added to the NASDAQ, AMEX and NYSE naked short threshold
list: Ethan Allen Interiors Inc. (NYSE: ETH), National City Corp.
(NYSE: NCC), Adept Technology Inc. (NASDAQ: ADEP), CombiMatrix Corp.
(NASDAQ: CBMX), Cell Genesys Inc. (NASDAQ: CEGE), DryShips Inc.
(NASDAQ: DRYS). For a complete list of companies on the naked short
list please visit our web site. To find the SqueezeTrigger Price before
a short squeeze starts in any stock, go to www.buyins.net.
Ethan Allen Interiors Inc. (NYSE: ETH) engages in manufacturing and
retailing home furnishings and accessories. The company involves in the
design, manufacture, sourcing, sale, and distribution of a range of
home furnishings and accessories, as well as related marketing and
brand awareness efforts. It also sells home furnishings and accessories
to consumers through a network of company-owned design centers. The
company's products include beds, dressers, armoires, tables, chairs,
buffets, entertainment units, home office furniture, bathroom vanities,
and wood accents. It also offers upholstery home furnishing items, such
as sleepers, recliners, chairs, sofas, loveseats, cut fabrics, and
leather, as well as home accessory and other items, including window
treatments, wall decor, lighting, clocks, bedspreads, decorative
accessories, area rugs, bedding, and home and garden furnishings. As of
June 30, 2007, the company sold its products through 313 retail design
centers comprising 158 company-owned and operated centers, and 155
independently-owned and operated centers. It sells its products in the
United States, Canada, the Middle East, and Asia. Ethan Allen Interiors
was founded in 1932 and is headquartered in Danbury, Connecticut. With
29.02 million shares outstanding and 10.97 million shares declared
short as of April 2008, there is a failure to deliver in shares of ETH.
According to quarterly data provided by the SEC, there were still
17,631 shares of ETH that were failing-to-deliver as of September 28,
2007.
National City Corp. (NYSE: NCC) a financial holding company, provides
commercial and retail banking, mortgage financing and servicing,
consumer finance, and asset management services in the United States.
Its retail banking services include deposit gathering and direct
lending services, business banking services, education finance, retail
brokerage, and lending-related insurance services to consumers and
small businesses. The company's consumer lending products include home
equity, student loans, and credit cards and other unsecured personal
and small business lines of credit. National City's commercial banking
products and services include lines of credit, term loans, leases,
investment real estate lending, asset-based lending, treasury
management, stock transfer, international services, and dealer
floorplan financing to large- and medium-sized corporations. The
company also offers loan sales and securitization, structured finance,
syndicated lending, commercial leasing, equity and mezzanine capital,
derivatives, public finance, investment banking, correspondent banking,
multifamily real estate lending, and commercial real estate lending to
select customers in certain industries or distribution channels. Its
mortgage banking activities comprise originating residential mortgage,
home equity lines, and loans collateralized by one-to-four-family
residential real estate, as well as servicing mortgage loans, home
equity loans, and home equity lines of credit for third-party
investors. National City's asset management services include investment
management, custody, retirement planning services, and other corporate
trust services to institutional clients; and personal wealth management
services for individuals and families. As of December 31, 2007, it
operated approximately 1,400 branch banking offices in Ohio, Florida,
Illinois, Indiana, Kentucky, Michigan, Missouri, Pennsylvania, and
Wisconsin. The company was founded in 1845 and is headquartered in
Cleveland, Ohio. With 648.14 million shares outstanding and 64.63
million shares declared short as of April 2008, there is a failure to
deliver in shares of NCC. According to quarterly data provided by the
SEC, there were still 50,544 shares of NCC that were failing-to-deliver
as of September 28, 2007.
Adept Technology Inc. (NASDAQ: ADEP) together with its subsidiaries,
provides intelligent robotics systems and services for packaged goods,
life sciences, disk drive/electronics, semiconductor, and machine tool
automation and automotive electronics sectors. Its product range
includes application software, integrated real-time vision and
multi-axis motion controls, machine vision systems and software,
industrial robots, and vision-based flexible parts feeders. The company
offers 4-axis Cobra family of robots, which are designed for assembly
and material handling tasks; Modular Adept Python single axis robot
mechanisms; Adept Viper 6-axis articulated robots for high-speed
precision assembly; and Adept Quattro robots for high-speed packaging
applications. It also provides support services to customers, including
spare parts for remanufacture of robot mechanisms; information
regarding the use of its automation equipment; ongoing support for
installed systems; consulting services for applications; and training
courses ranging from system operation and maintenance to programming
geared towards manufacturing engineers who design and implement
automation lines. Adept Technology markets and sells its products
through systems integrators, distributors, original equipment
manufacturers, and direct sales force in the United States, Europe, and
Asia. The company was founded in 1983 and is headquartered in
Livermore, California with additional offices in Cincinnati, Ohio;
Charlotte, North Carolina; Pomona, California; Vancouver, Canada;
Dortmund, Germany; Massy, France; and Singapore, Singapore. With 7.96
million shares outstanding and 3,200 shares declared short as of March
2008, there is a failure to deliver in shares of ADEP.
CombiMatrix Corp. (NASDAQ: CBMX) together with its subsidiaries,
develops technologies, products, and services in the areas of drug
development, genetic analysis, molecular diagnostics, nanotechnology
research, defense, and homeland security. Its technologies include a
platform to produce customizable, in-situ synthesized, and
oligonucleotide arrays for use in identifying and determining the roles
of genes, gene mutations, and proteins in the areas of genomics,
proteomics, biosensors, drug discovery, drug development, diagnostics,
combinatorial chemistry, material sciences, and nanotechnology. The
company's products and services include CustomArray platform, an
oligonucleotide array for genetic studies; CatalogArray Microarrays for
gene expression studies, mutation analysis, and other studies;
Micro-RNA Arrays that are used to study micro-RNA molecules; DNA Array
Synthesizer, an instrument that enables researchers to fabricate DNA
arrays to their exact specifications; stripping reagents, which enables
researchers to re-use microarrays; ElectraSense Reader, an
electrochemical scanning instrument; and comparative genomic
hybridization arrays, which are used for research and molecular
diagnostic applications. CombiMatrix also offers proprietary molecular
synthesis and screening methods for the discovery of potential new
drugs. In addition, it develops capabilities of producing arrays that
utilize bacterial artificial chromosomes that enable genetic analysis;
and a series of compounds to address various oncology-related diseases.
The company was founded in 1995 and is based in Mukilteo, Washington.
With 6.01 million shares outstanding and 138,500 shares declared short
as of March 2008, there is a failure to deliver in shares of CBMX.
Cell Genesys Inc. (NASDAQ: CEGE) a biotechnology company, engages in
the development and commercialization of biological therapies for
patients with cancer. It develops cell-based cancer immunotherapies and
oncolytic virus therapies. The company's GVAX cancer Immunotherapies
comprise Prostate Cancer, a phase III product for the treatment of
prostate cancer; Pancreatic Cancer, a phase II product for pancreatic
cancer; and Leukemia, a phase II product for the treatment of acute and
chronic myelogenous leukemia, and myelodysplastic syndrome. Its
Oncolytic Virus Therapy includes CG0070, a phase I product for the
treatment of recurrent bladder cancer. Cell Genesys has alliance with
Novartis AG for the development and commercialization of oncolytic
virus therapies; research and development collaboration with Medarex,
Inc.; and development and commercialization collaboration of GVAX
immunotherapy with Takeda Pharmaceutical Company Limited for prostate
cancer. The company was founded in 1988 and is headquartered in South
San Francisco, California. With 78.76 million shares outstanding and
17.7 million shares declared short as of March 2008, there is a failure
to deliver in shares of CEGE. According to quarterly data provided by
the SEC, there were still 21,032 shares of CEGE that were
failing-to-deliver as of September 27, 2007.
DryShips Inc. (NASDAQ: DRYS) engages in the ownership and operation of
drybulk carriers worldwide. The company's fleet carries various drybulk
commodities, including coal, iron ore, grains, bauxite, phosphate,
fertilizers, and steel products. As of March 14, 2008, it owned and
operated a fleet of 46 drybulk carriers comprising 5 Capesize, 31
Panamax, 2 Supramax, and 8 newbuilding drybulk vessels with a combined
deadweight tonnage of approximately 4 million tons. The company was
founded in 2004 and is headquartered in Athens, Greece. With 36.68
million shares outstanding and 5.16 million shares declared short as of
March 2008, there is a failure to deliver in shares of DRYS. According
to quarterly data provided by the SEC, there were still 158,220 shares
of DRYS that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of
publicly traded US companies fight naked short selling. Naked short
selling is the illegal act of short selling a stock when no affirmative
determination has been made to locate shares of the stock to
hypothecate in connection with the short sale. Buyins.net has built a
proprietary database that uses Threshold list feeds from NASDAQ, AMEX
and NYSE to generate detailed and useful information to combat the
naked short selling problem. For the first time, actual trade by trade
data is available to the public that shows the attempted size, actual
size, price and average value of short sales in stocks that have been
shorted and naked shorted. This information is valuable in determining
the precise point at which short sellers go out-of-the-money and start
losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and
publishes a proprietary SqueezeTrigger for each stock that has been
shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database
of nearly 1,950,000,000 short sale transactions goes back to January 1,
2005, and calculates the exact price at which the Total Short Interest
is short in each stock. This data was never before available prior to
January 1, 2005, because the Self Regulatory Organizations (primary
exchanges) guarded it aggressively. After the SEC passed Regulation
SHO, exchanges were forced to allow data processors like Buyins.net to
access the data.
The SqueezeTrigger database collects individual short trade data on
over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on
nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows
by approximately 50,000,000 short sale transactions and provides
investors with the knowledge necessary to time when to buy and sell
stocks with outstanding short positions. By tracking the size and price
of each month's short transactions, BUYINS.NET provides institutions,
traders, analysts, journalists and individual investors the exact price
point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information
believed to be reliable. The information contained herein is not
guaranteed by BUYINS.NET to be accurate, and should not be considered
to be all-inclusive. The companies that are discussed in this opinion
have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and
uncertainties. This material is for informational purposes only and
should not be construed as an offer or solicitation of an offer to buy
or sell securities. BUYINS.NET is not a licensed broker, broker dealer,
market maker, investment banker, investment advisor, analyst or
underwriter. Please consult a broker before purchasing or selling any
securities viewed on or mentioned herein. BUYINS.NET may receive
compensation in cash or shares from independent third parties or from
the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have
bought or may buy the shares discussed in this opinion and may profit
in the event those shares rise in value. Market commentary provided by
Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not
and will not offer any opinion as to when others should sell; each
investor must make that decision based on his or her judgment of the
market.
This release contains "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, as amended, and Section
21E the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
"Forward-looking statements" describe future expectations, plans,
results, or strategies and are generally preceded by words such as
"may", "future", "plan" or "planned", "will" or "should", "expected,"
"anticipates", "draft", "eventually" or "projected". You are cautioned
that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results
to differ materially from those projected in the forward-looking
statements, including the risks that actual results may differ
materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies'
annual report on Form 10-K or 10-KSB and other filings made by such
company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking
statements included herein, and not place undue reliance on such
statements. The forward-looking statements in this release are made as
of the date hereof and BUYINS.NET undertakes no obligation to update
such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET
Tel: +1 800 715 9999
e-mail: Tom@buyins.net
WWW: http://www.buyins.net
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, January 20-22, 2010. Miami, FL.
